Showing results (301-310 of 411) with videos related to
Sort By:
Pageof 42
Biorxiv : the Preprint Server for Biology|September 10, 2024
AcrIF11 is a potent CRISPR-specific ADP-ribosyltransferase encoded by phage and plasmidDaphne F Chen, Leah T Roe, Yuping Li, et al.Cell Reports|February 15, 2018
Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass CytometryVeronica D Gonzalez, Nikolay Samusik, Tiffany J Chen, et al.Molecular Cancer Therapeutics|June 17, 2015
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast CancerYeon-Jin Kwon, Kevin Petrie, Boris A Leibovitch, et al.Plos Pathogens|August 31, 2023
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivoTaha Y Taha, Rahul K Suryawanshi, Irene P Chen, et al.Molecular & Cellular Proteomics : MCP|January 14, 2023
TEAD Proteins Associate With DNA Repair Proteins to Facilitate Cellular Recovery From DNA DamagePhilamer C Calses, Victoria C Pham, Alissa D Guarnaccia, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy in vivoPriyadarshini Jaishankar, Galen J Correy, Yusuke Matsui, et al.Journal of Medicinal Chemistry|December 17, 2025
Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy In VivoPriyadarshini Jaishankar, Galen J Correy, Yusuke Matsui, et al.Cancer Cell|June 24, 2022
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistenceJulia A Belk, Winnie Yao, Nghi Ly, et al.Proceedings of the National Academy of Sciences of the United States of America|April 11, 2007
Analysis of PALB2/FANCN-associated breast cancer familiesMarc Tischkowitz, Bing Xia, Nelly Sabbaghian, et al.Cancer Research|October 18, 2017
ATR Is a Therapeutic Target in Synovial SarcomaSamuel E Jones, Emmy D G Fleuren, Jessica Frankum, et al.Pageof 42